Following a comprehensive review of products currently sold in the United Kingdom, Cardinal Health have taken the decision to discontinue a number of products effective from the 1st July 2022, effecting our Kendall, Kerlix and Telfa lines.
For a complete list of the affected products from our Medical Products portfolio, please click on the link https://qrco.de/bcitcA or copy the address into your web browser.
Where available, an alternative product has been identified.
Cardinal Health hopes that by communicating this list of discontinued products in advance will enable you to plan and prepare for a smooth transition. Click the image below to read the statement in full.
